Publication:
Uric acid in metabolic syndrome: from an innocent bystander to a central player

Placeholder

Departments

Organizational Unit

School / College / Institute

Organizational Unit
SCHOOL OF MEDICINE
Upper Org Unit

Program

KU Authors

Co-Authors

Jensen, Thomas
Solak, Yalçın
Le, Myphuong
Roncal-Jimenez, Carlos
Rivard, Chris
Lanaspa, Miguel A.
Nakagawa, Takahiko
Johnson, Richard J.

Publication Date

Language

Type

Embargo Status

Journal Title

Journal ISSN

Volume Title

Alternative Title

Abstract

Uric acid, once viewed as an inert metabolic end-product of purinemetabolism, has been recently incriminated in a number of chronic disease states, including hypertension, metabolic syndrome, diabetes, non- alcoholic fatty liver disease, and chronic kidney disease. Several experimental and clinical studies support a role for uric acid as a contributory causal factor in these conditions. Here we discuss some of the major mechanisms linking uric acid to metabolic and cardiovascular diseases. At this time the key to understanding the importance of uric acid in these diseases will be the conduct of large clinical trials in which the effect of lowering uric acid on hard clinical outcomes is assessed. Elevated uric acid may turn out to be one of the more important remediable risk factors for metabolic and cardiovascular diseases.

Source

Publisher

Elsevier

Subject

Medicine, General and internal medicine

Citation

Has Part

Source

European Journal of Internal Medicine

Book Series Title

Edition

DOI

10.1016/j.ejim.2015.11.026

item.page.datauri

Link

Rights

Copyrights Note

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details